A recent trial showed that β-OHB supplementation inhibited vascular calcification in chronic renal disease (CKD) via modulation of the histone deacetylase (HDAC) 9-dependent nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway [58]. The gene discussed is NFKB1; the disease is chronic kidney disease.